IL206905A0 - 4-(pyrrolo[2,3-c]pyridine-3-yl)pyrimidin-2- - Google Patents

4-(pyrrolo[2,3-c]pyridine-3-yl)pyrimidin-2-

Info

Publication number
IL206905A0
IL206905A0 IL206905A IL20690510A IL206905A0 IL 206905 A0 IL206905 A0 IL 206905A0 IL 206905 A IL206905 A IL 206905A IL 20690510 A IL20690510 A IL 20690510A IL 206905 A0 IL206905 A0 IL 206905A0
Authority
IL
Israel
Prior art keywords
pyrrolo
pyrimidin
pyridine
Prior art date
Application number
IL206905A
Other languages
English (en)
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of IL206905A0 publication Critical patent/IL206905A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL206905A 2008-01-22 2010-07-08 4-(pyrrolo[2,3-c]pyridine-3-yl)pyrimidin-2- IL206905A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102008005493A DE102008005493A1 (de) 2008-01-22 2008-01-22 4-(Pyrrolo[2,3-c] pyridine-3-yl)-pyrimidin-2-yl-amin-derivate
PCT/EP2008/011098 WO2009092431A1 (de) 2008-01-22 2008-12-23 4-(pyrrolo[2,3-c]pyridine-3-yl)-pyrimidin-2-amin-derivative

Publications (1)

Publication Number Publication Date
IL206905A0 true IL206905A0 (en) 2010-12-30

Family

ID=40386204

Family Applications (1)

Application Number Title Priority Date Filing Date
IL206905A IL206905A0 (en) 2008-01-22 2010-07-08 4-(pyrrolo[2,3-c]pyridine-3-yl)pyrimidin-2-

Country Status (14)

Country Link
US (1) US20100292262A1 (OSRAM)
EP (1) EP2231664A1 (OSRAM)
JP (1) JP5524864B2 (OSRAM)
KR (1) KR20100112626A (OSRAM)
CN (1) CN101918404A (OSRAM)
AR (1) AR070212A1 (OSRAM)
AU (1) AU2008348816B2 (OSRAM)
BR (1) BRPI0821936A2 (OSRAM)
CA (1) CA2712612A1 (OSRAM)
DE (1) DE102008005493A1 (OSRAM)
IL (1) IL206905A0 (OSRAM)
MX (1) MX2010007927A (OSRAM)
WO (1) WO2009092431A1 (OSRAM)
ZA (1) ZA201005959B (OSRAM)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101723936B (zh) * 2008-10-27 2014-01-15 上海睿星基因技术有限公司 激酶抑制剂及其在药学中的用途
EP2714688B1 (en) 2011-05-26 2016-02-24 Daiichi Sankyo Company, Limited Heterocyclic compounds as protein kinase inhibitors
TWI623531B (zh) 2012-11-21 2018-05-11 Ｐｔｃ治療公司 經取代反向嘧啶ｂｍｉ－１抑制劑
TWI663166B (zh) 2013-04-24 2019-06-21 健生藥品公司 新化合物
JP6524094B2 (ja) * 2013-08-30 2019-06-05 ピーティーシー セラピューティクス， インコーポレイテッド 置換ピリミジンＢｍｉ−１阻害剤
TWI627173B (zh) 2013-09-26 2018-06-21 比利時商健生藥品公司 作為ＮＩＫ抑制劑的新穎３－（１Ｈ－吡唑－４－基）－１Ｈ－吡咯并［２，３－ｃ］吡啶衍生物
TWI704146B (zh) 2013-09-26 2020-09-11 比利時商健生藥品公司 用作ＮＩＫ抑制劑之新的1-(４-嘧啶基)-１Ｈ-吡唑並[３,２-ｃ]吡啶衍生物
US10584115B2 (en) 2013-11-21 2020-03-10 Ptc Therapeutics, Inc. Substituted pyridine and pyrazine BMI-1 inhibitors
EP3209663B1 (en) 2014-10-23 2018-12-12 Janssen Pharmaceutica N.V. New pyrazolopyrimidine derivatives as nik inhibitors
US10323045B2 (en) 2014-10-23 2019-06-18 Janssen Pharmaceutica Nv Thienopyrimidine derivatives as NIK inhibitors
KR102499862B1 (ko) 2014-10-23 2023-02-13 얀센 파마슈티카 엔.브이. Ｎｉｋ 억제제로서의 신규 피라졸 유도체
ES2718557T3 (es) * 2014-10-23 2019-07-02 Janssen Pharmaceutica Nv Nuevos compuestos como inhibidores de nik
US12023335B2 (en) 2018-08-17 2024-07-02 Ptc Therapeutics, Inc. Method for treating pancreatic cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747469A (en) 1991-03-06 1998-05-05 Board Of Regents, The University Of Texas System Methods and compositions comprising DNA damaging agents and p53
GB9904387D0 (en) 1999-02-25 1999-04-21 Pharmacia & Upjohn Spa Antitumour synergistic composition
GB0308466D0 (en) 2003-04-11 2003-05-21 Novartis Ag Organic compounds
EP1773807A2 (en) * 2004-06-14 2007-04-18 Takeda San Diego, Inc. Kinase inhibitors
WO2006050076A1 (en) 2004-10-29 2006-05-11 Janssen Pharmaceutica, N.V. Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders
CN101801971A (zh) * 2005-09-30 2010-08-11 沃泰克斯药物股份有限公司 可用作janus激酶抑制剂的脱氮嘌呤
DE102006012617A1 (de) * 2006-03-20 2007-09-27 Merck Patent Gmbh 4-(Pyrrolopyridinyl)-pyrimidinyl-2-amin-derivate

Also Published As

Publication number Publication date
JP2011510028A (ja) 2011-03-31
ZA201005959B (en) 2011-04-28
DE102008005493A8 (de) 2010-03-25
KR20100112626A (ko) 2010-10-19
CN101918404A (zh) 2010-12-15
CA2712612A1 (en) 2009-07-30
EP2231664A1 (de) 2010-09-29
DE102008005493A1 (de) 2009-07-23
AU2008348816B2 (en) 2011-10-20
WO2009092431A1 (de) 2009-07-30
MX2010007927A (es) 2010-08-09
US20100292262A1 (en) 2010-11-18
JP5524864B2 (ja) 2014-06-18
AU2008348816A1 (en) 2009-07-30
BRPI0821936A2 (pt) 2015-06-16
AR070212A1 (es) 2010-03-25

Similar Documents

Publication Publication Date Title
IL206905A0 (en) 4-(pyrrolo[2,3-c]pyridine-3-yl)pyrimidin-2-
PL2013208T3 (pl) Pirydyno[3,4-B]pirazynowy
EP2265616B8 (en) Furo-and thieno[3,2-c]pyridines
IL197393A0 (en) Pyridin-4-yl derivatives as immunomodulating agents
IL207845A0 (en) Pyrazole [3,4-b] pyridine raf inhibitors
ZA200906736B (en) New 3-([1,2,4] Triazolo [4,3-A]Pyridin-7-YL) Benzamide derivatives
ZA201004524B (en) Pyrido[2,3-b]pyrazine-8-substituted compounds and their use
ZA201108124B (en) Pyrrolo [2,3-b] pyridines which inhibit raf protein kinase
BRPI0919948A2 (pt) Pirido[4,3-b]indois contendo porções rígidas
ZA201108885B (en) 3-([1,2,3]triazole-4yl)-pyrrolo[2,3-b]pyridine derivates
ZA201005338B (en) Pyrrolo[2,3-d]pyridines and use thereof as tyrosine kinase inhibitors
IL211136A0 (en) Pyrido [5,4-d] pyrimidines as cell proliferation inhibitors
PL2155712T3 (pl) 3-(imidazolilo)-pirazolo[3,4-b]pirydyny
PL2124944T3 (pl) Pochodne pirazolo[3,4-b]pirydyny jako inhibitory fosfodiesterazy
IL214426A0 (en) [1,2,4] triazollo [1,5-a] pyridines as kinase inhibitors
ZA201101861B (en) Compositions with and process for methylmorpholin-substituted pyrido [2,3-d] pyrimidines
EP2142542A4 (en) NEW IMIDAZO [4,5-B] PYRIDINE-7-CARBOXYLAMIDEAMIDE 704
IL207972A0 (en) Pyridin-2-yl derivatives as immunomodulating agents
ZA200805756B (en) 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2-methylaminoquinazoline derivative
IL206666A0 (en) N-PHENYLIMIDAZO[1,2-a]PYRIDINE-2-
ZA201105257B (en) 3-(3-pyrimidin-2-yl-benzyl)-[1,2,4]triazolo[4,3-b]pyrimidine derivatives
IL206668A0 (en) N-PHENYLIMIDAZO[1,2-a]PYRIDINE-2-
GB0714815D0 (en) Pyrazolo[3,4-b]pyridine compounds, and their use as PDE4 inhibitors
HK1160846A (en) [1, 2, 4] triazolo [1, 5 -a] pyridines as kinase inhibitors
HK1139943A (en) New imidazo [4,5-b] pyridine-7-carboxamides 704